MORE ARTICLES
The House Call – Cambridge Adopts a Zoning Ordinance Allowing 4 to 6-Story Residential Buildings CitywideMarch 10, 2025 - 11:44 am
Closing the Doors, Leaving a Legacy: Embark Microschool’s StoryMarch 6, 2025 - 12:28 pm
Study: Inclusionary Zoning Helps Some, but Can Jeopardize Broad-Based AffordabilityMarch 6, 2025 - 9:43 am
UK Oxford’s Robin Lane Fox on Homer & The IliadMarch 5, 2025 - 10:24 am
Director/Actor Samuel Lee Fudge on Marcus Garvey & Pan-AfricanismFebruary 26, 2025 - 1:31 pm
State Report Card on Telehealth Reform: Progress Slowed in 2024 Leaving Patients Without AccessFebruary 26, 2025 - 12:02 pm
Wildflower’s 70+ Microschools, Eight Years Later: Did Matt’s Vision Become Reality?February 20, 2025 - 2:31 pm
Pioneer Institute Study Says MA Housing Permitting Process Needs Systemic ReformFebruary 19, 2025 - 7:09 pm
Cornell’s Margaret Washington on Sojourner Truth, Abolitionism, & Women’s RightsFebruary 19, 2025 - 1:08 pm
UK Oxford & ASU’s Sir Jonathan Bate on Shakespeare’s Romeo and Juliet & LoveFebruary 14, 2025 - 11:41 am
Stay Connected!
Receive the latest updates in your inbox.
Pipelines Are Infrastructure: Colonial Incident Reveals Dark Side of Cyber Vulnerability
/in Economic Opportunity, Featured, Podcast Hubwonk /by Editorial StaffThis week on Hubwonk, Host Joe Selvaggi talks with cyber security expert Dr. Brandon Valeriano about the Colonial Pipeline shutdown and our national exposure to cyberattack on vital infrastructure.
A Rush to Judgment on Alzheimer’s Drug
/0 Comments/in Oped: Healthcare /by William SmithThe Boston-based Institute for Clinical and Economic Review (ICER) sells itself as an independent source of information on the value of pharmaceuticals. But earlier this month, their bias was again evident when they tried to kneecap a drug for a dreaded disease before there’s even enough data to determine how valuable the drug really is. ICER has adopted this same strategy in the past on innovative drugs for cancer, cystic fibrosis, and other devastating diseases. This time ICER’s target is aducanumab, Biogen’s drug for Alzheimer’s disease.
A Republic of Laws – The U.S. Supreme Court – 40 Resources for High School Students
/0 Comments/in COVID Education, COVID education resources, Featured /by Jamie GassIn Pioneer’s ongoing series of blogs on curricular resources for parents, families, and teachers during COVID-19, this one focuses on: Celebrating the U.S. Supreme Court.
Larry O’Toole on Workplace Culture & Immigration Policy
/in Blog: Economy, Economic Opportunity, Featured, JobMakers /by Editorial StaffOn this week’s episode of JobMakers, host Denzil Mohammed talks to Larry O’Toole, founder of the multi-state Gentle Giant Moving Company that started in 1980 right here in the Boston area. They discuss Mr. O’Toole’s journey at a young age from Ireland to Brookline, Mass., the challenges of being uprooted, and the ability to thrive despite barriers such as skills gaps, that many immigrants face.
Law Prof. Melvin Urofsky on Justice Louis Brandeis, the SCOTUS, & Dissenting Opinions
/in Civil Rights Education, Civil Rights Podcasts, Featured, Podcast, US History /by Editorial StaffThis week on “The Learning Curve,” Gerard and Cara talk with Melvin Urofsky, Professor of Law & Public Policy and Professor Emeritus of History at Virginia Commonwealth University, and the author of several books, including Louis D. Brandeis: A Life and Dissent and the Supreme Court. Professor Urofsky shares insights on Justice Brandeis’s jurisprudence, and why he consistently ranks among the three most influential Supreme Court justices in American history.